Significantly increase in circulating CD34+/CD133+ and CD34+ progenitor cells in moderate-severe AD compared to controls. Significantly inverse correlation between the number of circulating CD34+/CD133+ and CD34+ progenitor cells, cognitive function, and age in AD patients. This evidence concerns the gene PROM1 and Alzheimer disease.